2019 VISTA is the Website for LPBI Group’s Three Health Care Contents Asset Classes prospected for technology ownership transfer and monetization
- Executive Summary
- Opportunities Map in the Acquisition Arena
- Dynamic Contents for LPBI Group’s PowerPoint Presentation
- Detailed Technology Description
- Curation Methodology – Digital Communication Technology to mitigate Published Information Explosion and Obsolescence in Medicine and Life Sciences
- Top Authors by Number of eReaders Views
- Top Articles by Number of e-Readers for All Days ending 2019-02-17
- LPBI Group’s Social Media Presence
- Financial Valuation of Three Health Care Intellectual Property (IP) Content Asset Classes
- Global Market Penetration Forecast for each Volume in the 16 Volume BioMed e-Series
- Potential Use of LPBI IP as Value Price Driver by Potential Acquirer: Assumptions per Asset Class
- Financial Advisory & Legal Advisory Providers: US & Israel
- Founder’s Role in the Development of Venture’s Factors of Content Production – Biographical Notes by Aviva Lev-Ari, PhD, RN, LPBI Group
- FIT Members Contribute to Opportunities Map
- FINAL IMPROVEMENT TEAM (FIT): Definition of Active, Lapsing of Active Status, COMPs Formulas
- Mostly HONORED to be followed by [from an Excerpt of 117 Followers of the Twitter Account @AVIVA1950 from the List of 359 Followers] by the Number of their Followers on 2/24/2019
- LPBI Group is mostly HONORED to be followed by [from an Excerpt of 136 Followers of the Twitter Account @pharma_BI from the List of 505 Followers] by the Number of their Followers on 3/20/2019
- FIT members – Who works on WHAT?
- Comparative Analysis of the Level of Engagement for Four Twitter Accounts: @KDNuggets (Big Data) @GilPress @Forbes @pharma_BI @AVIVA1950
- MEDIA organizations as Followers of @pharma_BI the Official Twitter Account of LPBI Group (136 out of 505 Followers): Number of Followers’ Followers, Institutions (I) and Individuals (Persons(P)), RED = Mostly Honored to be followed by
- JOURNAL Statistics on 2/24/2019
- Excerpt of 136 Followers of @pharma_BI (from the List of 505 Followers) by the Number of their Followers on 3/20/2019
- Excerpt of 117 Followers of @AVIVA1950 (from the List of 359 Followers) by the Number of their Followers
- REACH – Two Handles on Twitter.com @AVIVA1950 @pharma_BI
- 2013-2019, On the Medical & Scientific Bookshelf in Kindle Store: eReader Behaviors: Browsing, Page Downloads and Buying e-Books – LPBI Group’s BioMed e-Series, Royalties Payment Analysis
- Connections First Level on LinkedIn: 500 CEOs, 200 Big Pharma Professionals, 7,000 in Total: LPBI Group Founder – Aviva Lev-Ari, PhD, RN
- Summer 2019 Plan – Research Associates Tasks
- LPBI’s Pipeline Map: A Positioning Perspectives – An Outlook to the Future from the Present
Our Team
- Aviva Lev-Ari, PhD, RN, Director and Founder
- Members of the Board
- Senior Editors
- Experts, Authors, Writers (EAWs)
- Business Development & Private Equity Investment
- Scientific Delegation Members & Patent Holders
- Inventors: Biologics
- Inventors: Medical Devices
- Research Assistants
- Research Associates
Advertisements
This page has the following sub pages.
- Executive Summary
- Opportunities Map in the Acquisition Arena
- Dynamic Contents for LPBI Group’s PowerPoint Presentation
- Detailed Technology Description
- Curation Methodology – Digital Communication Technology to mitigate Published Information Explosion and Obsolescence in Medicine and Life Sciences
- Top Authors by Number of e-Readers Views
- Top Articles by Number of e-Readers for All Days ending 2019-02-17
- LPBI Group’s Social Media Presence
- Financial Valuation of Three Health Care Intellectual Property (IP) Content Asset Classes
- Global Market Penetration Forecast for each Volume in the 16 Volume BioMed e-Series
- Potential Use of LPBI IP as Value Price Driver by Potential Acquirer: Assumptions per Asset Class
- Financial Advisory & Legal Advisory Providers: US & Israel
- Founder’s Role in the Development of Venture’s Factors of Content Production – Biographical Notes by Aviva Lev-Ari, PhD, RN, LPBI Group
- Final Improvement Team (FIT) Members Contribute to Opportunities Map & Define LPBI Uniqueness
- FINAL IMPROVEMENT TEAM (FIT): Definition of Active, Lasping of Active Status, COMPs Formulas
- HONORED to be followed by [from an Excerpt of 117 Followers of the Twitter Account @AVIVA1950 from the List of 359 Followers] by the Number of their Followers on 2/24/2019
- LPBI Group is mostly HONORED to be followed by [from an Excerpt of 136 Followers of the Twitter Account @pharma_BI from the List of 505 Followers] by the Number of their Followers on 3/20/2019
- Comparative Analysis of the Level of Engagement for Four Twitter Accounts: @KDNuggets (Big Data) @GilPress @Forbes @pharma_BI @AVIVA1950
- MEDIA organizations as Followers of @pharma_BI the Official Twitter Account of LPBI Group (136 out of 505 Followers): Number of Followers’ Followers, Institutions (I) and Individuals (Persons(P)), RED = Mostly Honored to be followed by
- FIT members – Who works on WHAT?
- JOURNAL Statistics from Inception, Data retrieved on 2/24/2019
- Excerpt of 136 Followers of @pharma_BI (from the List of 505 Followers) by the Number of their Followers on 3/20/2019
- Excerpt of 117 Followers of @AVIVA1950 (from the List of 359 Followers) by the Number of their Followers
- REACH – Two Handles on Twitter.com @AVIVA1950 @pharma_BI
- 2013-2019, On the Medical & Scientific Bookshelf in Kindle Store: eReader Behaviors: Browsing, Page Downloads and Buying e-Books – LPBI Group’s BioMed e-Series, Royalties Payment Analysis
- Connections First Level on LinkedIn: 500 CEOs, 200 Big Pharma Professionals, 7,000 in Total: LPBI Group Founder – Aviva Lev-Ari, PhD, RN
- Summer 2019 Plan – Research Associates Tasks
- LPBI’s Pipeline Map: A Positioning Perspectives – An Outlook to the Future from the Present
2012pharmaceutical
Aashir Awan, Phd
Alan F. Kaul, PharmD., MS, MBA, FCCP
alexcrystal6
amnondanzig1724
anamikasarkar
apreconasia
aviralvatsa
David Orchard-Webb, PhD
danutdaagmailcom
Demet Sag, Ph.D., CRA, GCP
Dror Nir
evelinacohn
Gail S Thornton
Irina Robu
jdpmd
kellyperlman
Ed Kislauskis
larryhbern
lmulligan13gmailcom
marzankhan
megbaker58
pkandala
Rosalind Codrington, PhD
ritusaxena
Rick Mandahl
sjwilliamspa
stuartlpbi
Dr. Sudipta Saha
tildabarliya
zraviv06
zs22